A detailed history of Group One Trading, L.P. transactions in Allakos Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 98,649 shares of ALLK stock, worth $125,284. This represents 0.0% of its overall portfolio holdings.

Number of Shares
98,649
Holding current value
$125,284
% of portfolio
0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.54 - $0.92 $53,270 - $90,757
98,649 New
98,649 $64,000
Q1 2024

May 10, 2024

SELL
$1.02 - $3.23 $26,764 - $84,755
-26,240 Reduced 73.76%
9,333 $11,000
Q4 2023

Feb 14, 2024

BUY
$1.72 - $3.18 $43,786 - $80,953
25,457 Added 251.65%
35,573 $97,000
Q3 2023

Nov 09, 2023

BUY
$2.13 - $5.55 $17,453 - $45,476
8,194 Added 426.33%
10,116 $22,000
Q2 2023

Aug 09, 2023

BUY
$3.6 - $5.25 $6,919 - $10,090
1,922 New
1,922 $8,000
Q2 2022

Aug 11, 2022

BUY
$2.6 - $6.14 $125,138 - $295,518
48,130 Added 553.47%
56,826 $178,000
Q1 2022

May 12, 2022

SELL
$5.08 - $9.81 $302,742 - $584,626
-59,595 Reduced 87.27%
8,696 $50,000
Q4 2021

Feb 11, 2022

BUY
$8.55 - $111.89 $524,362 - $6.86 Million
61,329 Added 880.91%
68,291 $669,000
Q3 2021

Nov 12, 2021

SELL
$76.53 - $110.43 $228,748 - $330,075
-2,989 Reduced 30.04%
6,962 $737,000
Q2 2021

Aug 10, 2021

BUY
$85.37 - $114.1 $849,516 - $1.14 Million
9,951 New
9,951 $850,000
Q1 2021

May 12, 2021

SELL
$109.73 - $153.66 $867,744 - $1.22 Million
-7,908 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$79.58 - $152.45 $629,318 - $1.21 Million
7,908 New
7,908 $1.11 Million
Q3 2020

Nov 12, 2020

SELL
$66.43 - $90.99 $134,919 - $184,800
-2,031 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$44.04 - $80.69 $136,524 - $250,139
-3,100 Reduced 60.42%
2,031 $146,000
Q1 2020

May 13, 2020

BUY
$44.49 - $93.39 $228,278 - $479,184
5,131 New
5,131 $228,000
Q4 2019

Feb 10, 2020

SELL
$66.49 - $137.73 $482,983 - $1 Million
-7,264 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$31.0 - $89.73 $225,184 - $651,798
7,264 New
7,264 $571,000

Others Institutions Holding ALLK

About Allakos Inc.


  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $108M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.